High-frequency oscillatory ventilation Versus intermittent mandatory ventilation : early hemodynamic effects in the premature baboon with hyaline membrane disease

• Published in: Pediatric research Vol. 29; no. 2; pp. 160 - 166
• Main Authors: KINSELLA, J. P, GERSTMANN, D. R, CLARK, R. H, NULL, D. M, MORROW, W. R, TAYLOR, A. F, DELEMOS, R. A
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD Lippincott Williams & Wilkins 01.02.1991
• Subjects: Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Animals; Animals, Newborn; Biological and medical sciences; Hemodynamics - physiology; High-Frequency Ventilation - adverse effects; Humans; Hyaline Membrane Disease - physiopathology; Hyaline Membrane Disease - therapy; Infant, Newborn; Intensive care medicine; Intermittent Positive-Pressure Ventilation - adverse effects; Medical sciences; Papio; Respiratory Mechanics - physiology; Premature; Intermittent mandatory ventilation; Treatment; Disease; Respiratory disease; Respiratory intensive care; Hemodynamics; Hyaline membrane; Technique; High frequency ventilation; Resuscitation; Comparative study
• ISSN: 0031-3998; 1530-0447
• DOI: 10.1203/00006450-199102000-00012

We studied the hemodynamic consequences during the first 24 h of life in premature baboons (140 d) with hyaline membrane disease that were treated with high-frequency oscillatory ventilation (HFOV) or conventional intermittent mandatory ventilation (IMV). Cardiac output and organ blood flow were measured at three time-points using the radiolabeled microsphere technique. Seven of seven HFOV and six of eight IMV animals survived the 24-h period. By design, initial mean airway pressure (Paw) was higher in the HFOV group (p less than 0.01). HFOV Paw was progressively reduced during the study period because of improving oxygenation as measured by the arterial to alveolar oxygen ratio. In contrast, it was necessary to increase Paw in the IMV animals to maintain the arterial to alveolar oxygen ratio. By 23 h, the IMV group required higher Paw than the HFOV group (p less than 0.05) and had a lower arterial to alveolar oxygen ratio (p less than 0.05). We found no significant differences in left ventricular output, effective systemic flow, organ blood flow, or central venous pressure between the two groups at 3, 8, or 23 h. The HFOV strategy used in our study resulted in significant improvement in oxygenation during the initial 24 h of treatment without adverse effect on left ventricular output, cerebral blood flow, or central venous pressure. We conclude that when appropriate changes in Paw are made during HFOV in response to improvement in arterial oxygenation and changes in lung inflation as assessed by chest radiographs HFOV can be achieved without depressing cardiovascular dynamics more than during conventional therapy with IMV.